Severe hypomagnesaemia with tetany following ESHAP protocol
BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. This prompted a careful look at the incidence and severity of hypomagnesaemia during treatment with this combination chemotherapy. M...
I tiakina i:
| I whakaputaina i: | BMC Blood Disord |
|---|---|
| Kaituhi matua: | |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2002
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11801194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2326-2-1 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|